• 1. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 2. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 3. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 4. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Nitrobenzenes

Recent Advances in the Application of 1,4-Dibromo-2-fluoro-5-nitrobenzene (CAS: 366496-33-5) in Chemical Biology and Pharmaceutical Research

1,4-Dibromo-2-fluoro-5-nitrobenzene (CAS: 366496-33-5) is a halogenated nitrobenzene derivative that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various bioactive molecules, including pharmaceuticals, agrochemicals, and materials science applications. Recent studies have highlighted its role in the development of novel therapeutic agents and its utility in advanced synthetic methodologies.

One of the most notable applications of 1,4-Dibromo-2-fluoro-5-nitrobenzene is its use in the synthesis of kinase inhibitors, which are critical in the treatment of cancers and inflammatory diseases. A 2023 study published in the Journal of Medicinal Chemistry demonstrated the compound's efficacy as a building block for the development of selective JAK2 inhibitors, which show promise in treating myeloproliferative neoplasms. The study reported a 40% improvement in yield compared to traditional synthetic routes, underscoring the compound's potential for scalable production.

In addition to its pharmaceutical applications, 1,4-Dibromo-2-fluoro-5-nitrobenzene has been employed in materials science for the development of organic semiconductors. A recent publication in Advanced Materials (2024) detailed its use in the synthesis of π-conjugated polymers with enhanced charge carrier mobility. The researchers attributed this improvement to the electron-withdrawing properties of the nitro and fluoro substituents, which facilitate efficient electron transport.

From a synthetic chemistry perspective, novel catalytic systems have been developed to optimize the functionalization of 1,4-Dibromo-2-fluoro-5-nitrobenzene. A 2023 Nature Communications paper reported a palladium-catalyzed cross-coupling reaction that achieves >90% selectivity for the desired products, significantly reducing byproduct formation. This advancement addresses one of the major challenges in working with polyhalogenated aromatics.

The safety profile and environmental impact of 1,4-Dibromo-2-fluoro-5-nitrobenzene have also been subjects of recent investigation. Regulatory agencies are particularly interested in its biodegradation pathways, with a 2024 study in Environmental Science & Technology identifying two novel bacterial strains capable of degrading this compound under aerobic conditions. These findings may inform future waste management strategies for industrial-scale applications.

Looking forward, researchers anticipate expanded applications of 1,4-Dibromo-2-fluoro-5-nitrobenzene in PROTAC (Proteolysis Targeting Chimera) technology and click chemistry approaches. Early-stage research presented at the 2024 ACS National Meeting suggests its potential as a versatile linker moiety for targeted protein degradation platforms. The compound's unique combination of reactivity and stability makes it particularly suitable for these emerging therapeutic modalities.

• 701-45-1(2-Bromo-1-fluoro-4-nitrobenzene)
• 350699-92-2(2-Bromo-3,4-difluoro-1-nitrobenzene)
• 557789-62-5(1,3-Dibromo-2-fluoro-4-nitrobenzene)
• 898128-02-4(1,3-Dibromo-5-fluoro-2-nitrobenzene)
• 700-36-7(2-Bromo-4-fluoro-1-nitrobenzene)
• 59255-94-6(2-Bromo-1-fluoro-3-nitrobenzene)
• 446-09-3(1-Bromo-4-fluoro-2-nitrobenzene)
• 144450-58-8(2,4-Dibromo-1,5-difluoro-3-nitrobenzene)
• 877161-74-5(2-Bromo-1,5-difluoro-3-nitrobenzene)
• 1020718-01-7(2-Bromo-3,4,5-trifluoro-1-nitrobenzene)